中國核電(601985.SH):擬出資2.55億元參設莊河核電
格隆匯2月23日丨中國核電(601985.SH)公佈,根據國家能源發展戰略和公司的發展規劃,公司擬與大唐核電和大連國資共同出資設立莊河核電。莊河核電註冊資本為5億元,公司擬出資2.55億元,佔莊河核電註冊資本的51%。
大唐核電為公司重要控股子公司持股10%以上的其他股東,持有中核遼寧核電有限公司24%股權。根據《上海證券交易所股票上市規則》的規定,公司與大唐核電共同投資設立莊河核電構成關聯交易。
公司設立莊河核電符合國家能源發展戰略和產業政策,是公司及各股東方響應國家“碳中和、碳達峯”的具體舉措,同時能夠促進區域經濟發展,保障能源安全並進一步提高公司建設和運行“華龍一號”核電機組的能力,更好的促進公司發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.